Company News
Company News
Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022
January 15, 2022
Vancouver, British Columbia, Canada – January 15, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce, as a follow up...
Read more
Company News
Core One Labs Now Also Working to Biosynthesize DMT and Receives License
January 08, 2022
Vancouver, British Columbia, Canada – January 8, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that it has progressed...
Read more
Company News
Core One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments
January 05, 2022
Vancouver, British Columbia, Canada – January 5, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) applauds Health Canada for its recent amendment...
Read more
Company News
Core One Labs Acquires New Path Laboratories
December 23, 2021
Vancouver, British Columbia, Canada – December 23, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is a research and development company...
Read more
Company News
CORE ONE LABS APPLAUDS THE CITY OF SEATTLE IN THEIR EFFORTS TO DECRIMINALIZE PSYLOCIBIN AND OTHER NATURAL OCCURING ENTHEOGENIC DRUGS
October 16, 2021
Vancouver, British Columbia, October 16, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (FWB: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing...
Read more
Company News
CORE ONE LABS ACQUIRES FRONTIER MYCOLOGY
August 17, 2021
Vancouver, British Columbia, Canada – August 17, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”)...
Read more